OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reiterated by analysts at FinnCap in a research note issued to investors on Wednesday.

OptiBiotix Health PLC (OPTI) opened at 70.50 on Wednesday. OptiBiotix Health PLC has a 52-week low of GBX 59.00 and a 52-week high of GBX 90.00. The firm’s market cap is GBX 55.10 million. The company’s 50-day moving average price is GBX 64.50 and its 200-day moving average price is GBX 70.78.

COPYRIGHT VIOLATION WARNING: “OptiBiotix Health PLC (OPTI) Stock Rating Reaffirmed by FinnCap” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/optibiotix-health-plc-opti-stock-rating-reaffirmed-by-finncap/1530645.html.

OptiBiotix Health PLC Company Profile

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.